Attenuation of cerebrospinal fluid inflammation by the nonbacteriolytic antibiotic daptomycin versus that by ceftriaxone in experimental pneumococcal meningitis

Antimicrobial Agents and Chemotherapy

Volumn 54, Issue 3, 2010, Pages 1323-1326

  Grandgirard, Denis ^a   Oberson, Kevin ^a   Bühlmann, Angela ^a   Gäumann, Rahel ^a   Leib, Stephen L ^a  

^a UNIVERSITY OF BERN   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CEFTRIAXONE; CXCL1 CHEMOKINE; DAPTOMYCIN; GAMMA INTERFERON; GRANULOCYTE COLONY STIMULATING FACTOR; INTERLEUKIN 10; INTERLEUKIN 18; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERLEUKIN 6; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MONOCYTE CHEMOTACTIC PROTEIN 1; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; ATTENUATION; BACTERICIDAL ACTIVITY; BRAIN DAMAGE; CEREBROSPINAL FLUID; COMPARATIVE STUDY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG BLOOD LEVEL; EXPERIMENTAL MODEL; EXPERIMENTAL PNEUMOCOCCAL MENINGITIS; INFLAMMATION; MAXIMUM PLASMA CONCENTRATION; NONHUMAN; PNEUMOCOCCAL MENINGITIS; PRIORITY JOURNAL; RAT; STREPTOCOCCUS PNEUMONIAE; WISTAR RAT;

ANIMALS; ANIMALS, NEWBORN; ANTI-BACTERIAL AGENTS; CEFTRIAXONE; CEREBROSPINAL FLUID; DAPTOMYCIN; DISEASE MODELS, ANIMAL; HUMANS; INFLAMMATION; MENINGITIS, PNEUMOCOCCAL; RATS; RATS, WISTAR; TREATMENT OUTCOME;

EID: 77149180391     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00812-09     Document Type: Article

References (20)

1. Baltz, R. H. 2009. Daptomycin: mechanisms of action and resistance, and biosynthetic engineering. Curr. Opin. Chem. Biol. 13:144-151.
2. Bifrare, Y. D., C. Gianinazzi, H. Imboden, S. L. Leib, and M. G. Täuber. 2003. Bacterial meningitis causes two distinct forms of cellular damage in the hippocampal dentate gyrus in infant rats. Hippocampus 13:481-488.
3. Cottagnoud, P., M. Pfister, F. Acosta, M. Cottagnoud, L. Flatz, F. Kuhn, H. P. Muller, and A. Stucki. 2004. Daptomycin is highly efficacious against penicillin-resistant and penicillin- and quinolone-resistant pneumococci in experimental meningitis. Antimicrob. Agents Chemother. 48:3928-3933.
4. Egermann, U., Z. Stanga, A. Ramin, F. Acosta, A. Stucki, P. Gerber, M. Cottagnoud, and P. Cottagnoud. 2009. The combination of daptomycin plus ceftriaxone was more active than vancomycin plus ceftriaxone in experimental meningitis after addition of dexamethasone. Antimicrob. Agents Chemother. 53:3030-3033.
5. Gehre, F., S. L. Leib, D. Grandgirard, J. Kummer, A. Bühlmann, F. Simon, R. Gäumann, A. S. Kharat, M. G. Täuber, and A. Tomasz. 2008. Essential role of choline for pneumococcal virulence in an experimental model of meningitis. J. Intern. Med. 264:143-154.
6. Gerber, J., W. Bruck, C. Stadelmann, S. Bunkowski, H. Lassmann, and R. Nau. 2001. Expression of death-related proteins in dentate granule cells in human bacterial meningitis. Brain Pathol. 11:422-431.
7. Grandgirard, D., C. Schürch, P. Cottagnoud, and S. L. Leib. 2007. Prevention of brain injury by the nonbacteriolytic antibiotic daptomycin in experimental pneumococcal meningitis. Antimicrob. Agents Chemother. 51:2173-2178.
8. Lee, D. H., B. Palermo, and M. Chowdhury. 2008. Successful treatment of methicillin-resistant staphylococcus aureus meningitis with daptomycin. Clin. Infect. Dis. 47:588-590.
9. Leib, S. L., C. Heimgartner, Y. D. Bifrare, J. M. Loeffler, and M. G. Täuber. 2003. Dexamethasone aggravates hippocampal apoptosis and learning deficiency in pneumococcal meningitis in infant rats. Pediatr. Res. 4:4.
10. Loeffler, J. M., R. Ringer, M. Hablutzel, M. G. Täuber, and S. L. Leib. 2001. The free radical scavenger alpha-phenyl-tert-butyl nitrone aggravates hippocampal apoptosis and learning deficits in experimental pneumococcal meningitis. J. Infect. Dis. 183:247-252.
11. Meli, D. N., S. Christen, S. L. Leib, and M. G. Täuber. 2002. Current concepts in the pathogenesis of meningitis caused by Streptococcus pneumoniae. Curr. Opin. Infect. Dis. 15:253-257.
12. Meli, D. N., R. S. Coimbra, D. G. Erhart, G. Loquet, C. L. Bellac, M. G. Täuber, U. Neumann, and S. L. Leib. 2006. Doxycycline reduces mortality and injury to the brain and cochlea in experimental pneumococcal meningitis. Infect. Immun. 74:3890-3896.
13. Mook-Kanamori, B. B., M. S. Rouse, C. I. Kang, D. van de Beek, J. M. Steckelberg, and R. Patel. 2009. Daptomycin in experimental murine pneumococcal meningitis. BMC Infect. Dis. 9:50.
14. Nau, R., and H. Eiffert. 2005. Minimizing the release of proinflammatory and toxic bacterial products within the host: a promising approach to improve outcome in life-threatening infections. FEMS Immunol. Med. Microbiol. 44:1-16.
15. Sakoulas, G., G. M. Eliopoulos, J. Alder, and C. T. Eliopoulos. 2003. Efficacy of daptomycin in experimental endocarditis due to methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 47:1714-1718.
16. Schuchat, A., K. Robinson, J. D. Wenger, L. H. Harrison, M. Farley, A. L. Reingold, L. Lefkowitz, and B. A. Perkins. 1997. Bacterial meningitis in the United States in 1995. Active Surveillance Team. N. Engl. J. Med. 337:970-976.
17. Spreer, A., R. Lugert, V. Stoltefaut, A. Hoecht, H. Eiffert, and R. Nau. 2009. Short-term rifampicin pretreatment reduces inflammation and neuronal cell death in a rabbit model of bacterial meningitis. Crit. Care Med. 37:2253-2258.
18. Stucki, A., M. Cottagnoud, V. Winkelmann, T. Schaffner, and P. Cottagnoud. 2007. Daptomycin produces an enhanced bactericidal activity compared to ceftriaxone, measured by [3H]choline release in the cerebrospinal fluid, in experimental meningitis due to a penicillin-resistant pneumococcal strain without lysing its cell wall. Antimicrob. Agents Chemother. 51:2249-2252.
19. Thallinger, C., M. Rothenburger, C. Marsik, S. Wuenscher, M. Popovic, G. Endler, O. Wagner, and C. Joukhadar. 2008. Daptomycin does not exert immunomodulatory effects in an experimental endotoxin model of human whole blood. Pharmacology 81:57-62.
20. van de Beek, D., J. de Gans, P. McIntyre, and K. Prasad. 2007. Corticosteroids for acute bacterial meningitis. Cochrane Database Syst. Rev. 2007: CD004405.